Thromboembolism in Patients with Cancer: A Practical Guide to Recurrent Events
Cancer patients have an increased risk of venous thromboembolism (VTE), and VTE is the second most common cause of death among them. Anticoagulation plays a key role in the treatment of cancer-associated thrombosis (CAT). Low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) are...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2024-11-01
|
Series: | Reviews in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/RCM/25/11/10.31083/j.rcm2511406 |